Vol 14, No 1 (2018)

Date published: 2018-02-28

Table of Contents

open access


Recommendations for assessment and management of pain in cancer patients

Wojciech Leppert, Jerzy Wordliczek

Guidelines / Expert consensus

DOI: 10.5603/OCP.2018.0005
Oncol Clin Pract 2018;14(1):1-14.

Management of extravasation of antineoplastic agents

Maryna Rubach

Guidelines / Expert consensus

DOI: 10.5603/OCP.2018.0006
Oncol Clin Pract 2018;14(1):15-22.

Personalised treatment of non-small-cell lung cancer patients — review of current evidence

Rafal Zysk, Maciej Krzakowski

Review paper

DOI: 10.5603/OCP.2018.0007
Oncol Clin Pract 2018;14(1):23-24.

Management of nivolumab-induced pulmonary toxicity — pneumonitis

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski

Review paper

DOI: 10.5603/OCP.2018.0001
Oncol Clin Pract 2018;14(1):35-39.

Immunotherapy of cancer — safety issues

Piotr Rutkowski

Review paper

DOI: 10.5603/OCP.2018.0002
Oncol Clin Pract 2018;14(1):40-42.

Dual HER2 blockade in adjuvant and neoadjuvant treatment of HER2-positive breast cancer: the role of pertuzumab

Renata Duchnowska

Review paper

DOI: 10.5603/OCP.2018.0008
Oncol Clin Pract 2018;14(1):43-47.

Treatment of patients with advanced melanoma harboring the BRAF V600 mutation

Joanna Połowinczak-Przybyłek, Piotr Potemski

Review paper

DOI: 10.5603/OCP.2018.0003
Oncol Clin Pract 2018;14(1):48-52.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl